Possible testing includes: A CMP or BMP when vomiting, diarrhea, poor fluid intake, or kidney risk is present Glucose review in people with diabetes A1C testing after enough time has passed to reflect a meaningful glycemic trend Additional tests based on previous abnormalities or new symptoms Stable Long-Term Monitoring A1C monitoring should follow the patient's diabetes status and treatment goals
The anti-inflammatory and antioxidant effects of GLP-1RAs observed in other organ systems may prevent damage in ocular tissues, leading to reduced risk of nonexudative age-related macular degeneration (AMD), exudative AMD, and primary open-angle glaucoma (POAG) compared to other diabetic medications (Figure 1)
While these drugs can be very effective, the first week is often a time of adjustment as your body gets used to the medication
About this article Cite this article Rosh, B., Obeid, H
PLoS ONE 10 , e0130894 (2015)